These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 12608045

  • 1. [Toxic lesions of the organ of vision caused by chloroquine derivatives].
    Kolotova AI, Ermakov NV.
    Vestn Oftalmol; 2003; 119(1):39-42. PubMed ID: 12608045
    [Abstract] [Full Text] [Related]

  • 2. [On ocular damage caused by chloroquine].
    Rinaldi G, Coslovich E, Tuvo F.
    Minerva Med; 1971 Feb 24; 62(16):766-9. PubMed ID: 5313741
    [No Abstract] [Full Text] [Related]

  • 3. [Chloroquine-induced bull's eye maculopathy without electrophysiologic changes].
    Cursiefen C, Grunert U, Jünemann A.
    Klin Monbl Augenheilkd; 1997 Jun 24; 210(6):400-1. PubMed ID: 9333669
    [Abstract] [Full Text] [Related]

  • 4. Ocular side effects of selected systemic drugs.
    Jaanus SD.
    Optom Clin; 1992 Jun 24; 2(4):73-96. PubMed ID: 1363080
    [Abstract] [Full Text] [Related]

  • 5. [Results of ophthalmologic examination in 54 patients undergoing prolonged treatment with antimalarials].
    David-Chaussé J, Bessière E, Vérin P, Magendie P.
    Rhumatologie; 1967 Jan 24; 19(1):17-26. PubMed ID: 6044716
    [No Abstract] [Full Text] [Related]

  • 6. [Ocular intoxication due to chloroquine and its derivatives. Importance of functional studies, ERG and EOG. Study of a series of 400 cases (1964-71)].
    Parizot H.
    Bull Soc Belge Ophtalmol; 1972 Jan 24; 160(2):570-80. PubMed ID: 4656811
    [No Abstract] [Full Text] [Related]

  • 7. [Ocular involvement in chloroquine therapy].
    Godel V, Nemet P, Stein R.
    Harefuah; 1972 Jul 16; 83(2):60-3. PubMed ID: 5068910
    [No Abstract] [Full Text] [Related]

  • 8. Ophthaproblem. Chloroquine or hydroxychloroquine retinopathy.
    Liu W, Sharma S.
    Can Fam Physician; 2005 May 16; 51(5):671, 679-80. PubMed ID: 15934269
    [No Abstract] [Full Text] [Related]

  • 9. [The changes in the electric retinal activity during resochin treatment].
    Svĕrák J, Peregrin J, Salavec M.
    Klin Monbl Augenheilkd; 1967 Nov 16; 151(5):633-40. PubMed ID: 5597424
    [No Abstract] [Full Text] [Related]

  • 10. RETINOPATHY DURING CHLOROQUINE THERAPY.
    Wilson W.
    Br J Ophthalmol; 1961 Nov 16; 45(11):756-8. PubMed ID: 18170732
    [No Abstract] [Full Text] [Related]

  • 11. [Ocular side effects of chloroquine treatment of rheumatoid arthritis patients].
    Glennås A, Brath HK, Bergaust B.
    Tidsskr Nor Laegeforen; 1980 May 10; 100(13):902-3. PubMed ID: 7385132
    [No Abstract] [Full Text] [Related]

  • 12. [Ocular changes caused by long-lasting use of chloroquine and its derivatives in rheumatoid disease].
    Drewnowska-Sochańska A, Kuprianowicz W, Petrus B.
    Klin Oczna; 1970 May 10; 40(4):499-503. PubMed ID: 5453064
    [No Abstract] [Full Text] [Related]

  • 13. Ocular side effects of chloroquine in patients with rheumatoid arthritis, systemic lupus erythematosus and scleroderma.
    Leecharoen S, Wangkaew S, Louthrenoo W.
    J Med Assoc Thai; 2007 Jan 10; 90(1):52-8. PubMed ID: 17621733
    [Abstract] [Full Text] [Related]

  • 14. Ocular damage in chloroquine therapy.
    Nylander U.
    Acta Ophthalmol (Copenh); 1966 Jan 10; 44(3):335-48. PubMed ID: 5953229
    [No Abstract] [Full Text] [Related]

  • 15. Visual function and long-term chloroquine treatment.
    Bartel PR, Roux P, Robinson E, Anderson IF, Brighton SW, van der Hoven HJ, Becker PJ.
    S Afr Med J; 1994 Jan 10; 84(1):32-4. PubMed ID: 8197491
    [Abstract] [Full Text] [Related]

  • 16. Chloroquine related cardiac toxicity.
    Veinot JP, Mai KT, Zarychanski R.
    J Rheumatol; 1998 Jun 10; 25(6):1221-5. PubMed ID: 9632091
    [Abstract] [Full Text] [Related]

  • 17. Some iatrogenic ocular diseases from systemically administered drugs.
    Bernstein HN.
    Int Ophthalmol Clin; 1970 Jun 10; 10(3):553-619. PubMed ID: 4933547
    [No Abstract] [Full Text] [Related]

  • 18. Chloroquine retinopathy. Investigation of discrepancy between dark adaptation and electroretinographic findings in advanced stages.
    Krill AE, Potts AM, Johanson CE.
    Am J Ophthalmol; 1971 Feb 10; 71(2):530-43. PubMed ID: 5547534
    [No Abstract] [Full Text] [Related]

  • 19. [Supervision of the eyes during prolonged treatment with synthetic antimalarial drugs. Results in 237 patients followed up for 4 years on the average].
    Bertrand JJ, Debeyre N, Kahn MF, Ryckewaert A.
    Presse Med (1893); 1968 Nov 23; 76(45):2139-42. PubMed ID: 5720115
    [No Abstract] [Full Text] [Related]

  • 20. Drug-induced macular disease.
    Potts AM.
    Trans Am Acad Ophthalmol Otolaryngol; 1966 Nov 23; 70(6):1054-7. PubMed ID: 5971468
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.